A Pilot Phase II Study for the evaluation of efficacy and tolerability of Gammaidroxybutyrate (ALCOVER) administered by oral route as add on treatmant in patients affected by DYT 11 Myoclonic Dystonia.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2011
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Dystonia
- Focus Therapeutic Use
- 08 Jun 2011 New trial record